RedHill Biopharma Ltd. (RDHL)

7.00
0.02 0.29
NASDAQ : Health Technology
Prev Close 6.98
Open 6.97
Day Low/High 6.96 / 7.05
52 Wk Low/High 4.30 / 11.25
Volume 29.51K
Avg Volume 81.60K
Exchange NASDAQ
Shares Outstanding 21.27M
Market Cap 150.79M
EPS -2.60
P/E Ratio 27.85
Div & Yield N.A. (N.A)

Latest News

Celgene Down After Pulling Plug on Crohn's Disease Drug Study -- Biotech Movers

Celgene Down After Pulling Plug on Crohn's Disease Drug Study -- Biotech Movers

The Summit, N.J.-based firm said Thursday that it was discontinuing the GED-0301 (mongersen) Phase 3 Revolve study in Crohn's disease and the extension trial.

TheStreet Quant Rating: D- (Sell)